2021 Top 500 ranking: 14
Vaccine developments are a clear positive, but the market’s reaction to the prospect of a post-coronavirus world creates some near-term uncertainty. We do not think this is the time to make a call on value versus growth. Instead, we believe this is the time to apply risk control and active ...
T. Rowe Price
Non-asset management investment service providers are able to purchase a subscription for access to premium content such as:
Get access to premium content subscribe today